Is Nephros, Inc.'s (NASDAQ:NEPH) CEO Paid At A Competitive Rate?HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Is Nephros, Inc.'s (NASDAQ:NEPH) CEO Paid At A Competitive Rate?Simply Wall StSimply Wall St.January 7, 2020ReblogShareTweetShareView photosDaron Evans became the CEO of Nephros, Inc. (NASDAQ:NEPH) in 2015. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we'll consider growth that the business demonstrates. And finally we will reflect on how common stockholders have fared in the last few years, as a secondary measure of performance. This method should give us information to assess how appropriately the company pays the CEO. See our latest analysis for Nephros How Does Daron Evans's Compensation Compare With Similar Sized Companies?According to our data, Nephros, Inc. has a market capitalization of US$75m, and paid its CEO total annual compensation worth US$497k over the year to December 2018. We think total compensation is more important but we note that the CEO salary is lower, at US$350k. We looked at a group of companies with market capitalizations under US$200m, and the median CEO total compensation was US$524k.That means Daron Evans receives fairly typical remuneration for the CEO of a company that size. While this data point isn't particularly informative alone, it gains more meaning when considered with business performance.You can see a visual representation of the CEO compensation at Nephros, below.NasdaqCM:NEPH CEO Compensation, January 7th 2020MoreIs Nephros, Inc. Growing?On average over the last three years, Nephros, Inc. has grown earnings per share (EPS) by 7.8% each year (using a line of best fit). Its revenue is up 63% over last year.I like the look of the strong year-on-year improvement in revenue. With that in mind, the modestly improving EPS seems positive. I wouldn't say this is necessarily top notch growth, but it is certainly promising. It could be important to check this free visual depiction of what analysts expect for the future.Has Nephros, Inc. Been A Good Investment?I think that the total shareholder return of 130%, over three years, would leave most Nephros, Inc. shareholders smiling. As a result, some may believe the CEO should be paid more than is normal for companies of similar size.In Summary...Remuneration for Daron Evans is close enough to the median pay for a CEO of a similar sized company .The company isn't showing particularly great growth, but shareholder returns have been pleasing. So all things considered I'd venture that the CEO pay is appropriate. CEO compensation is one thing, but it is also interesting to check if the CEO is buying or selling Nephros (free visualization of insider trades).Arguably, business quality is much more important than CEO compensation levels. So check out this free list of interesting companies, that have HIGH return on equity and low debt.If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoShould You Buy Antevenio, S.A. (EPA:ALANT) For Its Dividend?Simply Wall St.'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoHere's What Absolent Group AB (publ)'s (STO:ABSO) P/E Is Telling UsSimply Wall St.Stock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchThis company is revamping presentation softwareYahoo Finance VideoBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo Finance